Varenicline-13C2,15N2 Tartrate
|
|
Sicherheit
Varenicline-13C2,15N2 Tartrate Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
Labelled nicotinic a4 acetylcholine receptor partial agonist. Aid in smoking cessation.Varenicline-13C2,15N2 Tartrate Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Varenicline-13C2,15N2 Tartrate Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 3)Lieferanten
| Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
|---|---|---|---|---|---|
| Absin Bioscience Inc. | -- |
chenjw@absin.cn | CHINA | 6155 | 58 |
| Toronto Research Chemicals | -- |
info@trc-canada.com | Canada | 6884 | 71 |
| Medical Isotopes | -- |
stohler@medicalisotopes.com | United States | 6165 | 68 |
- 7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino[2,3-h][3]benzazepine (2R,3R)-2,3- Dihydroxybutanedioate-13C2,15N2
- Champix-13C2,15N2
- CP 526555-18-13C2,15N2
- Varenicline-13C2,15N2 Tartrate
- C1513C2H19N15N2O6
- Heterocyclic Compounds
- Heterocycles
- Intermediates & Fine Chemicals
- Isotope Labeled Compounds
- Pharmaceuticals




